The development of new drugs for acute stroke

Folia Pharmacologica Japonica

Volumn 116, Issue 6, 2000, Pages 379-384

  Suzuki, Y ^a   Umemura, K ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute stroke; Clinical trial; Investigational new drug

Indexed keywords

1 (BENZO[B]THIEN 5 YL) 2 (2 DIETHYLAMINOETHOXY)ETHANOL; 2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; APTIGANEL; CLOPIDOGREL; DV 7314; EBSELEN; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT; FONDAPARINUX; FOSPHENYTOIN SODIUM; GAVESTINEL; GLUTAMATE RECEPTOR ANTAGONIST; ISOCARBACYCLIN METHYL ESTER; MONTEPLASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; NIMODIPINE; NORPHENAZONE; REPINOTAN; SEROTONIN 1A RECEPTOR; TRAXOPRODIL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTICOAGULATION; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; FIBRINOLYTIC THERAPY; HUMAN; NERVE CELL NECROSIS; NEUROPROTECTION; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; STROKE;

EID: 0034528511     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.116.379     Document Type: Article

References (22)

1. CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
2. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
3. Abciximab in acute ischemic stroke: A randomized, double-blind, placebo-controlled, dose-escalation study
4. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial
5. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke
6. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke
7. Tissue plasminogen activator for acute ischemic stroke
8. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke
9. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
10. The rtPA (Alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): Results of a double-blind, placebo-controlled, multicenter study
11. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism
12. Selfotel in acute ischemic stroke: Possible neurotoxic effects of an NMDA antagonist
13. Ebselen in acute ischemic stroke: A placebo-controlled, doubleblind clinical trial
14. Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients
15. Nimodipine and perfusion changes after stroke
16. A randomized doseresponse trial of citicoline in acute ischemic stroke patients
17. A randomized efficacy trial of citicoline in patients with acute ischemic stroke
18. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial
19. Lubeluzole treatment of acute ischemic stroke